Biopharma IPOs Start to Gear Up For 2013 After a Lull
This article was originally published in The Pink Sheet Daily
Executive Summary
Biopharma and diagnostic IPOs have been relatively quiet since before the U.S. presidential election, but companies are again starting on road shows and updating prospectuses in anticipation of recaptured momentum.